(Reuters) -Moderna said on Friday it had filed a marketing application for an updated COVID vaccine to the U.S. Food and Drug Administration.
The company said the submission is based on guidance from the FDA, which advised that COVID-19 vaccines should be updated to target newer strains that are a part of JN.1 lineage, with a preference for the LP.8.1 variant.
(Reporting by Christy Santhosh in Bengaluru; Editing by Mohammed Safi Shamsi)
